US OptionsDetailed Quotes
LLY241220P935000
- 0.00
- 0.000.00%
15min DelayClose Dec 23 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest935.00Strike Price0.00Turnover0.00%IV-17.42%PremiumDec 20, 2024Expiry Date138.72Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
Nothing goes up forever, when it’s time for the fall, it just fall. You can lame it on FED or Powell but this pull back is a healthy one and an opportunity to buy the dip.
Once stable, we will probably see the the stocks trading around the same level until early next year. Hopefully by then the earnings season will provide some fuel for the stocks to move up.
$Eli Lilly and Co (LLY.US)$ $Tesla (TSLA.US)$ $Advanced Micro Devices (AMD.US)$ $Apple (AAPL.US)$ $Novo-Nordisk A/S (NVO.US)$ $Arm Holdings (ARM.US)$
...
Gapping up
$FedEx (FDX.US)$ stock soared 8.6% after the delivery giant reported better-than-expected earnings in the fiscal second quarter, while also announcing that it’s planning on spinning off its freight business.
$Eli Lilly and Co (LLY.US)$ stock rose 5.5%, with the drugmaker’s gains reflecting growing confidence in its competing obesity treatments.
Gapping down
$Nike (NKE.US)$ stock slumped 7.4% after the sports...
What is the market movers doing ?
If you don't see it, you are lying to yourself.
No comment yet